Moderna, Pfizer Nab Unanimous Votes For Pediatric COVID Vaccines But Advisors Hint At Moderna Dosing Advantage
FDA advisors signaled some preference for Moderna’s two-shot COVID-19 vaccine schedule in the youngest Americans over Pfizer’s three-shot series. • Source: Shutterstock
